...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease

Bear,

I completely understand your response to the question, but curious if you would be willing to offer your thoughts on the paragraph itself? It seemed to say that they did not, in fact, analyze for kidney function. I am not versed on the mode of operations for these trials. AT ALL. Thanks in advance.

Also, I seem to remember Dr. Kausik Ray telling you to "wait for a kidney conference" or something to get the kidney data you requested on Twitter. What gives?

Share
New Message
Please login to post a reply